title: Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.
abstract: Semliki Forest Virus (SFV) encephalomyelitis has been used to study the pathogenesis of virus-induced demyelination and serves as a model for multiple sclerosis. SFV-infection of mice invariably leads to clinical weakness accompanied by CNS inflammation, viral clearance and primary demyelination by day 21 postinfection (pi), followed by recovery and remyelination by day 35 pi. We have applied this model to the examination of the effects of γδ T cells in antibody production and the pathogenesis of demyelinating lesions. SFV-infection of γδ T cell KO mice resulted in more severe clinical signs than in wild type (WT) B6 mice. SFV-infected WT and γδ KO mice both cleared virus by day 10 pi and inflammation was comparable. Demyelination also appeared to be similar in both groups except that KO mice did not exhibit extensive remyelination which was seen in WT mice by day 21. SFV-infected WT mice showed widespread remyelination by day 35 pi, whereas KO mice still displayed some demyelination through day 42 pi. Both WT and KO mice developed serum antibodies to SFV. However, the reactivity of WT sera with the SFV epitope, E2 T(h) peptide₂, was significantly higher than in KO sera. Immunization with E2 T(h) peptide₂ resulted in elevated antibody production to this peptide (p<0.05) and earlier remyelination (day 28 pi) in KO mice. Thus, our study has shown for the first time that immunization of SFV-infected γδ T cell KO mice with a viral peptide, E2 T(h) peptide₂ led to enhanced recovery and repair of the CNS.
authors: Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
authors: Farinaz
authors: F
authors: Safavi
authors: Jason P
authors: JP
authors: Feliberti
authors: Cedric S
authors: CS
authors: Raine
authors: Foroozan
authors: F
authors: Mokhtarian
references: Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6452-6
references: 1830662
references: J Neuroimmunol. 2004 Jan;146(1-2):153-61
references: 14698858
references: FASEB J. 2002 Aug;16(10):1325-7
references: 12154009
references: Lab Invest. 1981 Dec;45(6):534-46
references: 7321526
references: Cell Immunol. 1989 Oct 1;123(1):23-35
references: 2476243
references: J Gen Virol. 1983 Jun;64 (Pt 6):1405-8
references: 6854274
references: J Immunol. 2003 Sep 1;171(5):2524-31
references: 12928402
references: Curr Biol. 1996 Oct 1;6(10):1317-25
references: 8939571
references: Cell Immunol. 1994 Aug;157(1):195-210
references: 7518751
references: Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9528-32
references: 1719533
references: Nature. 1987 Mar 5-11;326(6108):79-81
references: 3102971
references: J Neuroimmune Pharmacol. 2010 Sep;5(3):355-69
references: 19894121
references: J Immunol. 2005 Apr 15;174(8):4678-87
references: 15814692
references: Nature. 1988 Jun 30;333(6176):855-8
references: 2968521
references: J Immunol. 1994 Jun 1;152(11):5392-7
references: 8189058
references: J Immunol. 1993 Dec 1;151(11):6546-58
references: 8245484
references: J Virol. 2001 Jul;75(13):5860-9
references: 11390587
references: Lab Invest. 1984 Jun;50(6):608-35
references: 6202955
references: Lab Invest. 1984 Nov;51(5):534-46
references: 6208409
references: Immunol Rev. 2007 Feb;215:46-58
references: 17291278
references: Eur J Immunol. 1998 May;28(5):1681-8
references: 9603475
references: N Engl J Med. 2006 Mar 2;354(9):942-55
references: 16510748
references: Neurology. 2000 Aug 8;55(3):397-404
references: 10932275
references: Ann Neurol. 2004 Apr;55(4):458-68
references: 15048884
references: J Infect Dis. 2002 Dec 1;186 Suppl 2:S248-53
references: 12424705
references: Vaccine. 1998 Oct;16(16):1531-6
references: 9711800
references: Cell Immunol. 1992 Aug;143(1):183-93
references: 1320465
references: Cell Immunol. 1992 Aug;143(1):55-65
references: 1535834
references: J Immunol. 2001 Jun 1;166(11):6784-94
references: 11359837
references: J Immunol. 2004 Aug 1;173(3):1587-95
references: 15265886
references: J Neuroimmunol. 1999 Mar 1;95(1-2):43-54
references: 10229114
references: J Neuroimmunol. 2003 Apr;137(1-2):19-31
references: 12667644
references: J Gen Virol. 1991 Mar;72 ( Pt 3):557-65
references: 1706409
references: J Immunol. 1987 May 15;138(10):3264-8
references: 2437186
references: J Immunol. 1998 Jun 15;160(12):5955-62
references: 9637509
references: J Neurol Sci. 1990 May;96(2-3):293-302
references: 2376758
references: J Exp Med. 1989 Nov 1;170(5):1569-81
references: 2572671
references: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6820-5
references: 10841576
references: Arch Virol Suppl. 2004;(18):179-90
references: 15119773
references: Immunol Lett. 1989 Nov;23(1):49-53
references: 2532623
references: J Virol. 1993 Dec;67(12):7629-33
references: 7901429
references: J Exp Med. 1990 Oct 1;172(4):1225-31
references: 2145388
references: Neurology. 2009 Apr 7;72(14):1269-76
references: 19349608
references: J Immunol. 2000 Feb 15;164(4):2120-30
references: 10657666
references: Nature. 1988 Dec 1;336(6198):479-81
references: 2461518
references: J Virol. 1994 Oct;68(10):6291-8
references: 7916058
references: Eur J Immunol. 2000 Mar;30(3):747-58
references: 10741389
references: FASEB J. 2002 Aug;16(10):1260-2
references: 12060672
references: J Gen Virol. 1992 Sep;73 ( Pt 9):2267-72
references: 1383405
references: Am J Pathol. 2002 Oct;161(4):1255-63
references: 12368199
references: J Neuroimmunol. 1997 Mar;73(1-2):169-74
references: 9058773
references: J Immunol. 1996 Jul 15;157(2):941-9
references: 8752949
references: J Gen Virol. 1999 Sep;80 ( Pt 9):2287-2297
references: 10501479
references: Semin Immunol. 1991 Mar;3(2):99-108
references: 1832321
references: Curr Mol Med. 2009 Feb;9(1):15-22
references: 19199938
references: J Immunol. 2003 Nov 15;171(10):4979-83
references: 14607892
references: J Exp Med. 1987 Apr 1;165(4):1076-94
references: 2435832
references: Cell Immunol. 2000 Feb 25;200(1):27-35
references: 10716880
references: Cell. 1993 Feb 12;72(3):337-48
references: 8381716
references: J Immunol Methods. 1992 Nov 25;156(1):19-26
references: 1331242
references: J Neuroimmunol. 1997 May;75(1-2):204-9
references: 9143256
references: Mol Cell Neurosci. 2003 Jan;22(1):14-24
references: 12595235
references: J Autoimmun. 1998 Feb;11(1):105-10
references: 9480728
references: Neurology. 1996 Feb;46(2):538-45
references: 8614528
references: Neurobiol Dis. 2004 Feb;15(1):120-31
references: 14751777